90R3033 KRT-D
 
  By: Menéndez S.C.R. No. 1
 
 
 
CONCURRENT RESOLUTION
         WHEREAS, Lobular breast cancer, also known as invasive
  lobular carcinoma (ILC), accounts for 10 to 15 percent of all new
  breast cancer diagnoses in the U.S. each year; and
         WHEREAS, The second most common type of breast cancer, ILC
  originates in the lobules, or milk-producing glands, of the breast;
  according to the American Cancer Society, incidence rates of this
  subtype are rising faster than other cancers, and approximately
  48,000 new cases are diagnosed every year, with more than
  two-thirds occurring in women over the age of 60; and
         WHEREAS, ILC has distinct biological characteristics that
  make diagnosis and treatment particularly challenging; the tumors
  grow in single-file strands rather than in a lump, and they are also
  more likely to occur in more than one location or in both breasts;
  this makes physical examinations, screening, and advanced imaging
  tools such as mammography and ultrasound less reliable methods for
  early detection, often leading to later, more advanced stages of
  the disease at the time of diagnosis; and
         WHEREAS, Though chemotherapy is not generally effective
  against ILC, the majority of lobular tumors are hormone
  receptor-positive, making endocrine therapy a common treatment;
  however, genetic mutations can cause therapeutic resistance, and
  scientists are working to boost patient participation in clinical
  trials to help advance research surrounding treatments and
  management; and
         WHEREAS, To help focus attention on the disease, Lobular
  Breast Cancer Awareness Day takes place each year on October 15; the
  observance is recognized in numerous U.S. states as well as in
  countries around the globe, and the initiative is helping highlight
  the seriousness and prevalence of ILC and the importance of further
  medical studies; and
         WHEREAS, Lobular Breast Cancer Awareness Day plays an
  important role in fostering greater understanding of this
  potentially deadly disease, and this worthwhile initiative is
  helping to ensure that more people with ILC receive the timely care
  that they need; now, therefore, be it
         RESOLVED, That the 90th Legislature of the State of Texas
  hereby designate October 15 as Lobular Breast Cancer Awareness Day;
  and, be it further
         RESOLVED, That, in accordance with the provisions of Section
  391.004(d), Government Code, this designation remain in effect
  until the 10th anniversary of the date this resolution is finally
  passed by the legislature.